Prostate Cancer Care Disparity Analysis Project (ProGAP)
NCT06612034 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2025-07-24
Summary
This international cross-sectional study seeks to evaluate global disparities in prostate cancer management by conducting a thorough comparison of key elements across countries categorized as low-income, lower-middle-income, upper-middle-income, and high-income.
The primary question it addresses is: Are the standards of care for prostate cancer uniformly applied across different geographic regions worldwide? To achieve this, we will recruit physicians specializing in the diagnosis and treatment of prostate cancer from a diverse array of countries within these income classifications. Participants will complete a 17-question online survey.
Conditions
- Prostate CA
Interventions
- OTHER
-
No Intervention: Observational Cohort
No Intervention: Observational Cohort
Sponsors & Collaborators
-
Ankara University
lead OTHER
Principal Investigators
-
Yüksel Ürün · Ankara University
-
Deborah Mukherji · Clemenceau Medical Center Hospital Dubai
-
Mohammed Shahait · Al Zahra Hospital Dubai
-
Luis Castelo Branco · IOSI Oncologist Institute of Southern Switzerland
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-10
- Primary Completion
- 2025-10-30
- Completion
- 2025-10-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations
NCT02705846 ·Status: RECRUITING
-
Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer
NCT01734681 ·Status: WITHDRAWN ·Phase: PHASE2
-
Geriatric Assessment and Technology Evaluation in Prostate Cancer
NCT06215508 ·Status: RECRUITING
-
Implementation of Precision Medicine in High-risk Prostate Cancer
NCT06687421 ·Status: RECRUITING
-
ProA Study: ProActive Management Model in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated by Apalutamide
NCT06865547 ·Status: ENROLLING_BY_INVITATION
-
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer
NCT00967954 ·Status: UNKNOWN ·Phase: NA
-
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
NCT02080689 ·Status: COMPLETED ·Phase: NA
-
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
NCT06274047 ·Status: RECRUITING ·Phase: PHASE3
-
A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely
NCT05202301 ·Status: COMPLETED
-
A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
NCT02066961 ·Status: COMPLETED
-
Identifying the Best Follow up Approach for People Who Have Had Treatment to Cure Newly Diagnosed Prostate Cancer
NCT07264088 ·Status: NOT_YET_RECRUITING
-
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer
NCT03456843 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Symptom Management, Education and Telephone Follow-up, Quality of Life,
NCT05613881 ·Status: COMPLETED ·Phase: NA
-
Radiotherapy and Androgen Deprivation In Combination After Local Surgery (RADICALS) Translational Study
NCT06145958 ·Status: NOT_YET_RECRUITING
-
Prophylactic Prostatectomy for Prostate Cancer (PPPC)
NCT06470685 ·Status: ENROLLING_BY_INVITATION
-
Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer
NCT01511874 ·Status: COMPLETED ·Phase: PHASE4
-
Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer
NCT07216248 ·Status: RECRUITING ·Phase: PHASE2
-
PRospective Observational Study of STereotactic Body rAdiation Therapy With Androgen Deprivation Therapy for Organ-confined High-risk Prostate Cancer: the PROSTAR Trial
NCT06949254 ·Status: RECRUITING
-
Early Stage Prostate Cancer Cohort
NCT00011349 ·Status: COMPLETED
-
A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
NCT05303558 ·Status: COMPLETED
-
Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy
NCT00790595 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer
NCT06840535 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
NCT06136650 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomy
NCT02324998 ·Status: COMPLETED ·Phase: PHASE1
-
A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care
NCT02236637 ·Status: COMPLETED